We are live on ! Find out more
NOVT icon

Novanta

101.99 USD
-12.89
11.22%
At close Updated Nov 20, 4:00 PM EST
Pre-market
After hours
102.18
+0.19
0.19%
1 day
-11.22%
5 days
-11.41%
1 month
-24.78%
3 months
-29.91%
6 months
-33.6%
Year to date
-8.23%
1 year
2.79%
5 years
-39.05%
10 years
415.1%
 

About: Novanta Inc supplies core technology solutions to medical, life science, and advanced industrial OEMs, leveraging proprietary expertise in precision medicine, precision manufacturing, robotics and automation, and advanced surgery. It has two segments: Automation Enabling Technologies and Medical Solutions. Automation Enabling Technologies, which generates the majority of revenue, provides laser beam steering and scanning solutions, laser sources, and robotic and precision motion technologies. The Medical Solutions segment provides medical-grade technologies, including medical insufflators, endoscopic pumps, and integrated operating room technologies. The company operates in the United States, Germany, and other markets, with revenue generated from the United States.

Employees: 3,000

News

Positive
Neutral
Negative
Sentiment 3-Months
Positive 23.1%
Neutral 76.9%
Negative 0%
Neutral
Seeking Alpha
10 days ago
Novanta Inc. (NOVT) Q3 2026 Earnings Call Transcript
Novanta Inc. ( NOVT ) Q3 2026 Earnings Call November 10, 2026 8:00 AM EST Company Participants Marcella Meditz Matthijs Glastra - CEO & Chairman of the Board John Lesica - Co-Chief Operating Officer of Medical Solutions Charles Ravetto - Co-Chief Operating Officer of Automation Enabling Technologies Robert Buckley - Chief Financial Officer Conference Call Participants Lee Jagoda - CJS Securities, Inc. Brian Drab - William Blair & Company L.L.C., Research Division Presentation Operator Good morning.
Novanta Inc. (NOVT) Q3 2026 Earnings Call Transcript
Positive
MarketBeat
10 days ago
What Novanta (NOVT) Said on Its Q3 Earnings Call
Novanta NASDAQ: NOVT reported third-quarter revenue growth of 23% and its strongest organic growth in more than three years, as demand for robotics and advanced manufacturing products helped offset weakness in precision medicine. The company also completed its largest acquisition, Riverpoint Medical.
What Novanta (NOVT) Said on Its Q3 Earnings Call
Neutral
Business Wire
10 days ago
Novanta to Present at the Jefferies Global Healthcare Conference on Wednesday, November 18, 2026
BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Matthijs Glastra, Chair & Chief Executive Officer, and John Lesica, Chief Operating Officer of Medical Solutions, are scheduled to present at the Jefferies Global Healthcare Conference on Wednesday, November 18, 2026, in London. About Novanta Novanta is a leading global supplier of core technology solutions that g.
Novanta to Present at the Jefferies Global Healthcare Conference on Wednesday, November 18, 2026
Positive
Zacks Investment Research
11 days ago
Novanta (NOVT) Q3 Earnings and Revenues Surpass Estimates
Novanta (NOVT) came out with quarterly earnings of $1.05 per share, beating the Zacks Consensus Estimate of $0.97 per share. This compares to earnings of $0.87 per share a year ago.
Novanta (NOVT) Q3 Earnings and Revenues Surpass Estimates
Neutral
Business Wire
11 days ago
Novanta Announces Financial Results for the Third Quarter 2026
BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (“Novanta” or the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, today reported financial results for the third quarter 2026. Financial Highlights Three Months Ended   (In millions, except per share amounts) October 2,     September 26,     2026     2025   GAAP           Revenue $ 305.0     $ 247.8   Operating Income $ 13.9     $ 21.8   Net Income $ 2.0     $ 10.7   Diluted EPS $ 0.05    .
Novanta Announces Financial Results for the Third Quarter 2026
Neutral
Seeking Alpha
16 days ago
Baron Discovery Fund Q3 2026 Portfolio Activity
During the quarter, we initiated a position in Jersey Mike's Subs Inc., a franchisor of fast casual, submarine-style sandwich restaurants. We participated in the IPO of Lyntris Inc., a fast-growing proprietary defense solutions provider with a 90% sole-sourced portfolio exposed to many of the nation's key defense offerings. We sold our position in Wingstop Inc. during the quarter to allocate the proceeds into other restaurant companies where we felt there was better upside potential.
Baron Discovery Fund Q3 2026 Portfolio Activity
Neutral
ETF Trends
1 month ago
Human Data, Robot Hands: Where Automation Goes Next
High-quality real-world data has been a major bottleneck for teaching robot hands: A video can show movement without measuring touch or force.
Human Data, Robot Hands: Where Automation Goes Next
Neutral
Business Wire
1 month ago
Novanta to Present at the Baird 2026 Global Industrial Conference on Wednesday, November 11, 2026
BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Robert Buckley, Chief Financial Officer, and John Lesica, Chief Operating Officer of Medical Solutions, are scheduled to present at the Baird 2026 Global Industrial Conference on Wednesday, November 11, 2026, in Chicago, Illinois. About Novanta Novanta is a leading global supplier of core technology solutions that giv.
Novanta to Present at the Baird 2026 Global Industrial Conference on Wednesday, November 11, 2026
Neutral
ETF Trends
1 month ago
How to Invest in AI Drug Discovery
.Danaher (DHR), one of the world's largest providers of medical diagnostics and laboratory equipment, recently announced plans to launch its first AI-powered autonomous laboratory, scheduled to operate at commercial scale in early 2027. While market trading barely moved the stock on the announcement date, the news marks a quiet turning point for life science automation.
How to Invest in AI Drug Discovery
Neutral
Business Wire
1 month ago
Novanta Inc. Announces Schedule of Third Quarter 2026 Earnings Release and Conference Call
BOSTON--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its third quarter 2026 results after the close of U.S. financial markets on Monday, November 9, 2026. The Company will host a conference call on Tuesday, November 10, 2026 at 8:00 a.m. ET to discuss these results. To access the call, please dial (888) 346-3959 before the scheduled conference call time. Alternatively, the conf.
Novanta Inc. Announces Schedule of Third Quarter 2026 Earnings Release and Conference Call
Price charts implemented using Lightweight Charts™